Rs Arastirma Egitim Danismanlik Ilac Sanayi Ticaret A.s.

This early-phase study tested a new drug called RS-0139 in 16 people with advanced solid tumors that had come back or spread. The goal was to find the safest dose and see how the drug works in the body. The drug is designed to target tumors directly, and researchers monitored sid…